Experimental animal models of cerebral small vessel disease

Cerebral Small Vessel Disease

Volumn , Issue , 2011, Pages 42-51

  Hainsworth, Atticus H ^a   S Markus, Hugh ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84923490319     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781139382694.006     Document Type: Chapter

References (74)

1. Hainsworth AH, Markus HS. Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review. J Cereb Blood Flow Metab 2008; 28:1877-1891.
2. Imai H, Masayasu H, Dewar D, et al. Ebselen protects both grayand white matter in a rodent model of focal cerebral ischemia. Stroke 2001; 32:2149-2154.
3. Sarti C, Pantoni L. Experimental models of vascular dementia: a focus on white matter disease and incomplete infarction. In Bowler JV, Hachinski V, eds. Vascular Cognitive Impairment: Preventable Dementia. Oxford: Oxford University Press; 2003: pp. 76-92.
4. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010; 9:689-701.
5. Boiten J, Lodder J, Kessels F. Two clinically distinct lacunar infarctentities? A hypothesis. Stroke 1993; 24:652-656.
6. Fisher CM. The arterial lesions underlying lacunes. Acta Neuropathol 1968; 12:1-15.
7. Khan U, Porteous L, Hassan A, Markus HS. Risk factor profile of cerebral small vessel disease and its subtypes. J Neurol Neurosurg Psychiatry 2007; 78:702-706.
8. O’sullivan M, Lythgoe DJ, Pereira AC, et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 2002; 59:321-326.
9. Terborg C, Gora F, Weiller C, Rother J. Reduced vasomotor reactivity in cerebral microangiopathy: a study with near-infrared spectroscopy and transcranial Doppler sonography. Stroke 2000; 31:924-929.
10. Fernando MS, Simpson JE, Matthews F, et al. White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 2006; 37:1391-1398.
11. Hassan A, Hunt BJ, O’sullivan M, et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003; 126:424-432.
12. Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 2003; 34:806-812.
13. Giwa MO, Williams J, Elderfield K, et al. Neuropathologic evidence of endothelial changes in cerebral small vessel disease. Neurology 2012; 78:167-174.
14. Kaposzta Z, Young E, Bath PM, Markus HS. Clinical application of asymptomatic embolic signal detection in acute stroke: a prospective study. Stroke 1999; 30:1814-1818.
15. Bailey EL, McCulloch J, Sudlow C, Wardlaw JM. Potential animalmodels of lacunar stroke: a systematic review. Stroke 2009; 40: e451-e458.
16. Bailey EL, Wardlaw JM, Graham D, et al. Cerebral small vessel endothelial structural changes predate hypertension in stroke- prone spontaneously hypertensive rats: a blinded, controlled immunohistochemical study of 5- to 21-week-old rats. Neuropathol Appl Neurobiol 2011; 37:711-726.
17. Jiwa NS, Garrard P, Hainsworth AH. Experimental models of vascular dementia and vascular cognitive impairment. A systematic review. J Neurochem 2010; 115:814-828.
18. Sato Y, Chin Y, Kato T, et al. White matter activated glial cells produce BDNF in a stroke model of monkeys. Neurosci Res 2009; 65:71-78.
19. Walker EJ, Rosenberg GA. Divergent role for MMP-2 in myelin breakdown and oligodendrocyte death following transient global ischemia. J Neurosci Res 2010; 88:764-773.
20. Yamamoto Y, Shioda N, Han F, et al. Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation. Brain Res 2009; 1295:218-229.
21. Lai M, Horsburgh K, Bae SE, et al. Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischaemia. Eur J Neurosci 2007; 25:1832-1842.
22. Farkas E, Luiten PG, Bari F. Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev 2007; 54:162-180.
23. Ohta H, Nishikawa H, Kimura H, Anayama H, Miyamoto M. Chronic cerebral hypoperfusion by permanent internal carotidligation produces learning impairment without brain damage in rats. Neuroscience 1997; 79:1039-1050.
24. Sarti C, Pantoni L, Bartolini L, Inzitari D. Persistent impairment of gait performances and working memory after bilateral common carotid artery occlusion in the adult Wistar rat. Behav Brain Res 2002; 136:13-20.
25. Kitamura A, Fujita Y, Oishi N, et al. Selective white matter abnormalities in a novel rat model of vascular dementia. Neurobiol Aging 2012; 33:1012-1035.
26. Nishio K, Ihara M, Yamasaki N, et al. A mouse model characterizing features of vascular dementia with hippocampal atrophy. Stroke 2010; 41:1278-1284.
27. Shibata M, Ohtani R, Ihara M, Tomimoto H. White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 2004; 35:2598-2603.
28. Shibata M, Yamasaki N, Miyakawa T, et al. Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke 2007; 38:2826-2832.
29. Miki K, Ishibashi S, Sun L, et al. Intensity of chronic cerebral hypoperfusion determines white/ gray matter injury and cognitive/ motor dysfunction in mice. J Neurosci Res 2009; 87:1270-1281.
30. Yoshizaki K, Adachi K, Kataoka S, et al. Chronic cerebral hypoperfusion induced by right unilateral common carotid artery occlusion causes delayed white matter lesions and cognitive impairment in adult mice. Exp Neurol 2008; 210:585-591.
31. Kitagawa K, Yagita Y, Sasaki T, et al. Chronic mild reduction of cerebral perfusion pressure induces ischemic tolerance in focal cerebral ischemia. Stroke 2005; 36:2270-2274.
32. Lecrux C, McCabe C, Weir CJ, et al. Effects of magnesium treatment in a model of internal capsule lesion in spontaneously hypertensive rats. Stroke 2008; 39:448-454.
33. Whitehead SN, Hachinski VC, Cechetto DF. Interaction between a rat model of cerebral ischemia and ?-amyloid toxicity: inflammatory responses. Stroke 2005; 36:107-112.
34. Kemper TL, Blatt GJ, Killiany RJ, Moss MB. Neuropathology of progressive cognitive decline in chronically hypertensive rhesus monkeys. Acta Neuropathol (Berl) 2001; 101:145-153.
35. Ndung’u M, Hartig W, Wegner F, et al. Cerebral A?42 deposits and microvascular pathology in ageing baboons. Neuropathol Appl Neurobiol 2012; 38:487-499.
36. Rhyu IJ, Bytheway JA, Kohler SJ, et al. Effects of aerobic exercise training on cognitive function and cortical vascularity in monkeys. Neuroscience 2010; 167: 1239-1248.
37. Moss MB, Jonak E. Cerebrovascular disease and dementia: a primate model of hypertension and cognition. Alzheimers Dement 2007; 3: S6-S15.
38. Henning EC, Warach S, Spatz M. Hypertension-induced vascular remodeling contributes to reduced cerebral perfusion and the development of spontaneous stroke in aged SHRSP rats. J Cereb Blood Flow Metab 2010; 30:827-836.
39. Jalal F.Y, Yang Y, Thompson J, Lopez A.C, Rosenberg G.A. Myelin loss associated with neuroinflammation in hypertensive rats. Stroke 2012; 43:1115-1122.
40. Schreiber S, Bueche CZ, Garz C, et al. The pathologic cascade of cerebrovascular lesions in SHRSP: is erythrocyte accumulation an early phase? J Cereb Blood Flow Metab 2012; 32:278-290.
41. Lee JM, Zhai G, Liu Q, et al. Vascular permeability precedes spontaneous intracerebral hemorrhage in stroke-prone spontaneously hypertensive rats. Stroke 2007; 38:3289-3291.
42. Troen AM, Shea-Budgell M, Shukitt-Hale B, et al. B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice. Proc Natl Acad Sci USA 2008; 105:12474-12479.
43. Lee H, Kim JM, Kim HJ, Lee I, Chang N. Folic acid supplementation can reduce the endothelial damage in rat brain microvasculature due to hyperhomocysteinemia. J Nutr 2005; 135:544-548.
44. Mikael LG, Wang XL, Wu Q, et al. Hyperhomocysteinemia is associated with hypertriglyceridemia in mice with methylenetetrahydrofolate reductase deficiency. Mol Genet Metab 2009; 98:187-194.
45. Baumbach GL, Sigmund CD, Bottiglieri T, Lentz SR. Structure of cerebral arterioles in cystathionine ?-synthase-deficient mice. Circ Res 2002; 91:931-937.
46. Kamath AF, Chauhan AK, Kisucka J, et al. Elevated levels of homocysteine compromise blood-brain barrier integrity in mice. Blood 2006; 107:591-593.
47. Troen AM. The central nervous system in animal models of hyperhomocysteinemia. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29:1140-1151.
48. Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG. CADASIL. Lancet Neurol 2009; 8:643-653.
49. Joutel A, Monet-Lepretre M, Gosele C, et al. Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic modelof cerebral ischemic small vessel disease. J Clin Invest 2010; 120:433-445.
50. Wallays G, Nuyens D, Silasi- Mansat R, et al. Notch3 Arg170Cys knock-in mice display pathologic and clinical features of the neurovascular disorder cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Arterioscler Thromb Vasc Biol 2011; 31:2881-2888.
51. Ayata C. CADASIL: experimental insights from animal models. Stroke 2010; 41: S129-S134.
52. Araya R, Noguchi T, Yuhki M, et al. Loss of M5 muscarinic acetylcholine receptors leads to cerebrovascular and neuronal abnormalities and cognitive deficits in mice. Neurobiol Dis 2006; 24:334-344.
53. Kitamura N, Araya R, Kudoh M, et al. Beneficial effects of estrogen in a mouse model of cerebrovascular insufficiency. PLoS One 2009; 4:e51-e59.
54. Storozheva ZI, Proshin AT, Sherstnev VV, et al. Dicholine salt of succinic acid, a neuronal insulin sensitizer, ameliorates cognitive deficits in rodent models of normal aging, chronic cerebral hypoperfusion, and ?-amyloid peptide-(25-35) ?-induced amnesia. BMC Pharmacol 2008; 8:1.
55. Park L, Anrather J, Girouard H, Zhou P, Iadecola C. Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain. J Cereb Blood Flow Metab 2007; 27:1908-1918.
56. Cummings BJ, Head E, Ruehl W, Milgram NW, Cotman CW. The canine as an animal model of human aging and dementia. Neurobiol Aging 1996; 17:259-268.
57. Borras D, Ferrer I, Pumarola M. Age-related changes in the brain of the dog. Vet Pathol 1999; 36:202-211.
58. Head E, Mehta R, Hartley J, et al. Spatial learning and memory as a function of age in the dog. Behav Neurosci 1995; 109:851-858.
59. Elfenbein HA, Rosen RF, Stephens SL, et al. Cerebral ?-amyloid angiopathy in aged squirrel monkeys. Histol Histopathol 2007; 22:155-167.
60. LaFerla FM, Green KN. Animal models of Alzheimer disease. Cold Spring Harb Perspect Med 2012; 2: a006320.
61. Hamel E, Nicolakakis N, Aboulkassim T, Ongali B, TongXK. Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer’s disease. Exp Physiol 2008; 93:116-120.
62. Tsukuda K, Mogi M, Li JM, et al. Amelioration of cognitive impairment in the type-2 diabetic mouse by the angiotensin II type- 1 receptor blocker candesartan. Hypertension 2007; 50:1099-1105.
63. Takeda S, Sato N, Uchio-Yamada K, et al. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and A? deposition in an Alzheimer mouse model with diabetes. Proc Natl Acad Sci USA 2010; 107:7036-7041.
64. Yang C, Devisser A, Martinez JA, et al. Differential impact of diabetes and hypertension in the brain: adverse effects in white matter. Neurobiol Dis 2011; 42:446-458.
65. Landis SC, Amara SG, Asadullah K, et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature 2012; 490: 187-191.
66. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010; 8: e1000412.
67. Wang J, Zhang HY, Tang XC. Huperzine a improves chronic inflammation and cognitive decline in rats with cerebral hypoperfusion. J Neurosci Res 2010; 88:807-815.
68. Miyamoto N, Tanaka R, Shimura H, et al. Phosphodiesterase III inhibition promotes differentiation and survival of oligodendrocyte progenitors and enhances regeneration of ischemic white matter lesions in the adult mammalian brain. J Cereb Blood Flow Metab 2010; 30:299-310.
69. Fujita Y, Lin JX, Takahashi R, Tomimoto H. Cilostazol alleviates cerebral small-vessel pathology and white-matter lesions in stroke-prone spontaneously hypertensive rats. Brain Res 2008; 1203:170-176.
70. Dong YF, Kataoka K, Tokutomi Y, et al. Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats. J Pharmacol Exp Ther 2011; 339:358-366.
71. Bailey EL, Smith C, Sudlow CL, Wardlaw JM. Is the spontaneously hypertensive stroke prone rat a pertinent model of subcortical ischemic stroke? A systematic review. Int J Stroke 2011; 6:434-444.
72. Lammie GA. Hypertensive cerebral small vessel disease and stroke. Brain Pathol 2002; 12:358-370.
73. Holland PR, Bastin ME, Jansen MA, et al. MRI is a sensitive marker of subtle white matter pathology in hypoperfused mice. Neurobiol Aging 2011; 32:2325-2326.
74. Brittain JF, McCabe C, Khatun H, et al. An MRI-histological study of white matter in stroke-free SHRSP. J Cereb Blood Flow Metab 2013; 33:760-763.